Literature DB >> 19623031

Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.

Jason L Hornick1, Elizabeth A Bundock, Christopher D M Fletcher.   

Abstract

Benign nerve sheath tumors include neurofibromas, schwannomas, and perineuriomas. In recent years, nerve sheath tumors showing discrete areas of more than one histologic type have been described. We have recently recognized tumors showing hybrid features of schwannoma and soft tissue perineurioma. To characterize the clinicopathologic and immunohistochemical features of these lesions, 42 cases received between 1994 and 2008 were retrieved from authors' consult and surgical pathology files. Clinical details and follow-up were obtained from referring pathologists. Hematoxylin and eosin-stained sections were reexamined, and immunohistochemistry was performed. On 10 cases, double labeling with epithelial membrane antigen (EMA) and S100 protein was performed. Twenty-two patients were female and 20 were male (mean age, 38 y; range: 2 to 85; 71% second to fifth decades). Most patients presented with a solitary painless nodule. The tumors arose in a wide distribution: 19 lower limb, 12 upper limb, 6 head and neck, 4 trunk, and 1 colon. None of the patients showed signs of neurofibromatosis. Tumor size ranged from 0.7 to 17.5 cm (mean, 3 cm). Most tumors involved superficial subcutis (11 also dermis); only 3 were intramuscular. Histologically, the tumors were usually well circumscribed but unencapsulated, and composed of spindle cells with plump, tapering nuclei, and palely eosinophilic cytoplasm with indistinct cell borders, arranged in a storiform, whorled, and/or lamellar architecture. Only 1 tumor showed infiltrative margins. One tumor showed a plexiform growth pattern. Antoni A and B zonation and hyaline vessels were absent. Six tumors showed focally myxoid stroma and 11 contained scattered cells with degenerative nuclear atypia. Mitoses ranged from 0 to 4 per 30 high power fields; 32 tumors had no mitoses. All tumors showed staining for S100 protein and EMA; 98% were positive for CD34, 84% for GFAP, and 80% for claudin-1. Fourteen tumors contained rare neurofilament protein-positive axons. Double staining for EMA and S100 protein revealed parallel layers of alternating S100 and EMA-positive cells with no coexpression of antigens by the same cells. Most tumors were composed of approximately 60% to 70% of Schwann cells and 30% to 40% of perineurial cells. After a mean follow-up of 24 months (range, 6 to 60 mo), 1 tumor recurred locally, after incomplete excision. Benign nerve sheath tumors showing predominantly schwannian cytomorphology and perineurioma-like architecture are composed of an admixture of both cell types. These tumors usually arise in the dermis and subcutis and occur over a wide age range and anatomic distribution. Degenerative nuclear atypia (akin to that seen in ancient schwannoma and atypical neurofibroma) is relatively common. Hybrid schwannoma/perineuriomas have no evident association with neurofibromatosis and rarely recur. The pathogenetic basis of the dual pattern of differentiation in these lesions remains poorly understood at this time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623031     DOI: 10.1097/PAS.0b013e3181accc6c

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

Review 1.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

Review 2.  What's new in nerve sheath tumors.

Authors:  Anders Meyer; Steven D Billings
Journal:  Virchows Arch       Date:  2019-11-09       Impact factor: 4.064

3.  Proceedings of the 2012 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Brian R Berridge; Michael C Boyle; Michelle C Cora; Mark J Hoenerhoff; Linda Kooistra; Victoria A Laast; James P Morrison; Deepa Rao; Matthias Rinke; Katsuhiko Yoshizawa
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

Review 4.  Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:  Markku Miettinen
Journal:  Histopathology       Date:  2013-11-28       Impact factor: 5.087

5.  Inaccurate summary of peripheral nerve sheath tumors in extradigital sites. Comment on "Hybrid peripheral nerve sheath tumor of the nasal cavity showing schwannomatous, neurofibromatus, and perineuriomatous areas. Med Mol Morphol (2010) 43:82-85".

Authors:  Teresa Pusiol; Maria Grazia Zorzi; Doriana Morichetti; Francesco Piscioli
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

6.  Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors.

Authors:  Anne E Sarver; Aaron L Sarver; Venugopal Thayanithy; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 7.  Intraoral perineurioma, soft tissue type: report of five cases, including 3 intraosseous examples, and review of the literature.

Authors:  Ioannis G Koutlas; Bernd W Scheithauer; Andrew L Folpe
Journal:  Head Neck Pathol       Date:  2010-04-17

8.  Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants.

Authors:  Abbas Agaimy; Bruno Märkl; Julia Kitz; Peter H Wünsch; Hans Arnholdt; Laszlo Füzesi; Arndt Hartmann; Runjan Chetty
Journal:  Virchows Arch       Date:  2010-02-13       Impact factor: 4.064

9.  A soft tissue perineurioma and a hybrid tumor of perineurioma and schwannoma.

Authors:  Ji Young Park; Nam Jo Park; Sang Pyo Kim; Kun Young Kwon; Sang Sook Lee
Journal:  Korean J Pathol       Date:  2012-02-23

10.  Benign Cutaneous Peripheral Nerve Sheath Tumor with Hybrid Features: Report of Two Cases with Schwannoma/Perineurioma and Schwannoma/Neurofibroma Components.

Authors:  Shirien Shanouda; Gürkan Kaya
Journal:  Dermatopathology (Basel)       Date:  2017-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.